Esperion Therapeutics
ESPR
ESPR
99 hedge funds and large institutions have $186M invested in Esperion Therapeutics in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
6% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 31
2% less funds holding
Funds holding: 101 → 99 (-2)
12% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 17
Holders
99
Holding in Top 10
1
Calls
$2.99M
Puts
$661K
Top Buyers
| 1 | +$4.56M | |
| 2 | +$3.83M | |
| 3 | +$3.66M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$2.74M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.12M |
Top Sellers
| 1 | -$4.42M | |
| 2 | -$2.44M | |
| 3 | -$1.86M | |
| 4 |
IHM
Iguana Healthcare Management
New York
|
-$1.11M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$1.04M |